Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Social circles as medicine: tanzania study tests peer support for opioid recovery

NCT ID NCT04479475

Knowledge-focused Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a program that brings in family and friends to support people receiving methadone treatment for opioid use disorder in Tanzania. The goal was to see if this social support approach is acceptable and practical, and whether it helps people stick to their methadone and HIV medications. 58 people took part, including those on methadone and their chosen supporters. The study did not aim to cure addiction or HIV, but to learn if involving loved ones improves treatment adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

58 people

The number who actually took part.

Started

Mar 2024

Finished

Sep 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for MMT client participants in the intervention pilot: * 18 years old or older, * currently enrolled in the MAT program at the Muhimbili MAT clinic, * prescribed methadone for the past 3 months, * received a positive test result for heroin, cannabis or alcohol use in the past 3 months, * provide consent for trial participation. Inclusion criteria for social support persons in the intervention pilot: * 18 years old or older, * identified as a social support person of a MMT client participating in the pilot trial * lives in Dar es Salaam, * provide consent for trial participation. Exclusion Criteria: * Does not meet inclusion criteria

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adherence, medication are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease Medication Adherence opiate dependence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adherence, medication HIV infections Opioid use disorder

Contacts and locations

Locations

  • Muhimbili National Hospital

    Dar es Salaam, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.